DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Renzapride
Renzapride
Granisetron "Vianex"
Therapeutic Class Overview Irritable Bowel Syndrome Agents
Novel Formulations for Treatment of Migraine
5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: the Iceberg Still Lies Beneath the Surface
Gastroparesis: 2014
8-GI Drugs Final
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
CISAPRIDE (Veterinary—Systemic)
Investigating the Pharmacology of Novel 5-HT3 Receptor Ligands; with the Potential to Treat Neuropsychiatric and Gastrointestinal Disorders
A Phase 2B, Randomized, Multicenter, Double
(12) Patent Application Publication (10) Pub. No.: US 2016/0051466A1 FARR Et Al
Surveillance Review Proposal PDF 387 KB
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Efficacy and Tolerability of Renzapride in Irritable Bowel Syndrome: a Meta-Analysis of Randomized, Controlled Clinical Trials Including 2528 Patients
Stembook 2018.Pdf
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Top View
Pharmacology for Dentistry
Theoretical Study of the Interaction of Agonists with the 5-HT2A Receptor
(12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
Supplement 1 January 2009
Serotonin Receptors and Drugs Affecting Serotonergic Neurotransmission R ICHARD A
Pocket Guide to GASTROINTESTINAL DRUGS Edited by M
Treatment of Gastroparesis: a Multidisciplinary Clinical Review
5-HT Receptor Agonists in the Treatment of Gastrointestinal Motility Disorders
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Metoclopramide: a Template for Drug Discovery
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
History of Additional Plasma Metabolic Profile Data Submitted by the Firm HISTORY
Novel Strategies and Future Landmarks in the Treatment of Irritable Bowel Syndrome
Promotility Agents for the Treatment of Ileus in Adult Surgical Patients: a Practice Management Guideline from the Eastern University School of Medicine
Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders Meagan M
Print This Article
How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
Human Neurogenesis Assay: Ramelteon
(12) Patent Application Publication (10) Pub. No.: US 2003/0114475A1 Fox Et Al
Wo 2010/038241 A2
The Discovery, Use and Impact of Platinum Salts As Chemotherapy Agents for Cancer
Treatment of Irritable Bowel Syndrome: a Review
What Is the Role of Prokinetic Agents for Constipation?
NASDAQ: EVOK September 2019 Forward-Looking Statements
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Pathophysiological Concepts of Functional Dyspepsia and Irritable Bowel Syndrome Future Pharmacotherapy
Neuropharmacology of 5-Hydroxytryptamine
Information to Users
Irritable Bowel Syndrome)
CARD Lac and CAROTID VASCULAR EFFECTS of 5
5-HT 4 Receptor Ligands: Applications and New Prospects Michel Langlois, Rodolphe Fischmeister
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
New Therapeutic Perspectives in Irritable Bowel Syndrome: Targeting Low-Grade Inflammation, Immuno-Neuroendocrine Axis, Motility, Secretion and Beyond
Cancer Chemotherapy-Induced Nausea and Vomiting: Role of Mediators, Development of Drugs and Treatment Methods
(12) Patent Application Publication (10) Pub. No.: US 2010/0311704 A1 G00 Berman (43) Pub